Trial Profile
An Open-Labeled Multicenter Study to Investigate Plasma Levels and Catheter Tolerability Following Application of Paclitaxel Coated Balloon Catheter in Patients With Stenotic, or Occluded Femoro-Popliteal Arteries Due to Atherosclerosis.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Restenosis
- Focus Pharmacokinetics
- Sponsors Bayer; MEDRAD Interventional/Possis
- 13 Nov 2009 New trial record